Preprint Article Version 1 This version is not peer-reviewed

Comorbidity of Hypothyroidism and Low-Alanine Aminotransferase Associated Sarcopenia is Common and Associated with Shortened Survival. A Retrospective Study of 16,827 patients Over a Period of 21 Years

Version 1 : Received: 3 September 2024 / Approved: 4 September 2024 / Online: 4 September 2024 (13:34:43 CEST)

How to cite: Segal, O.; Khoury, R.; Vaisman, A.; Segal, G. Comorbidity of Hypothyroidism and Low-Alanine Aminotransferase Associated Sarcopenia is Common and Associated with Shortened Survival. A Retrospective Study of 16,827 patients Over a Period of 21 Years. Preprints 2024, 2024090374. https://doi.org/10.20944/preprints202409.0374.v1 Segal, O.; Khoury, R.; Vaisman, A.; Segal, G. Comorbidity of Hypothyroidism and Low-Alanine Aminotransferase Associated Sarcopenia is Common and Associated with Shortened Survival. A Retrospective Study of 16,827 patients Over a Period of 21 Years. Preprints 2024, 2024090374. https://doi.org/10.20944/preprints202409.0374.v1

Abstract

Background. Hypothyroidism is very common worldwide. It is known to be associated with frailty which in turn, is associated with increased morbidity and mortality in the elderlies. Low ALT blood activity is an established marker for sarcopenia and frailty. The incidence and outcomes of the association of low ALT values and hypothyroidism, as manifested in elevated blood TSH levels, is unknown. Methods. This was a retrospective analysis of hospitalized patients in a large, tertiary hospital. Results. Over a period of 21 years, an overall population of 16,827 patients were identified as eligible to participate in this study. Within the study population 726 (4.3%) were classified as suffering from hypothyroidism (TSH values > 6 MIU/L) and 2,184 (13%) were classified as patients with sarcopenia (ALT < 12 IU/L). Within our patients’ population, hypothyroidism was associated with sarcopenia in a statistically significant manner (p = 0.011). Patients classified as suffering from both hypothyroidism and sarcopenia had significantly shorter survival: A multivariate analysis showed that the frail and hypothyroid group of patients had a statistically significant risk of mortality in the for coming 5 years (HR = 3.6; CI 2.75-4.71; p < 0.001). Conclusions. Sarcopenia and frailty are common comorbidities, bearing negative long-term clinical outcomes. Low ALT values could serve as a useful biomarker for screening of patients already diagnosed with hypothyroidism.

Keywords

Hypothyroidism; Sarcopenia; Frailty; Survival; Alanine aminotransferase; Prognosis

Subject

Medicine and Pharmacology, Endocrinology and Metabolism

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.